Last $0.31 USD
Change Today -0.021 / -6.26%
Volume 981.0K
HEB On Other Exchanges
Symbol
Exchange
Frankfurt
As of 1:55 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles T. Bernhardt CPA, M.B.A.

Interim Chief Financial Officer, Echo Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

53--

Background*

Mr. Charles T. Bernhardt, CPA, MBA, has been an Interim Chief Financial Officer of Echo Therapeutics, Inc. since July 16, 2014. Mr. Bernhardt served as the Chief Financial Officer and Chief Accounting Officer of Hemispherx Biopharma, Inc. from January 1, 2009 to December 27, 2013. He served as a Director of Accounting for Healthcare Division of Thomson Reuters from 2006 to 2008. He was responsible for their Healthcare Division's accounting operations as well as the shared ...

Read Full Background

Corporate Headquarters*

One Penn Center
Philadelphia, Pennsylvania 19103

United States

Phone: 215-988-0080
Fax: 215-988-1739

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
Villanova University
MBA
West Chester University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.31 USD -0.021

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.